[Euconol in the treatment of patients with ischemic heart disease].
The clinical efficacy of the foodstuff euconol was studied in 72 patients with coronary heart diseases, stable angina of effort, postinfarct cardiosclerosis, or silent myocardial ischemia. A good antianginal effect was achieved in 51.4% of patients treated with euconol. At month 4 of treatment, the patients with coronary heart disease displayed a significant decrease in the number of anginal episodes and nitroglycerin tablets; this was followed by a reduction in the number and duration of silent myocardial ischemic episodes. It is concluded that a prolonged euconol intake causes positive changes in the blood lipid composition and natural history of coronary heart disease.
Vertkin
A L
AL
Martynov
I V
IV
Vasiagin
A I
AI
Shafranskiĭ
Iu A
IuA
Martynov
A I
AI
D000787:Angina Pectoris / Q000097:blood / Q000188:drug therapy / Q000503:physiopathology; D002784:Cholesterol / Q000097:blood; D004042:Dietary Fats, Unsaturated / Q000494:pharmacology / Q000627:therapeutic use*; D004562:Electrocardiography; D005215:Fasting; D005395:Fish Oils / Q000494:pharmacology / Q000627:therapeutic use*; D006801:Humans; D008074:Lipoproteins / Q000187:drug effects; D017202:Myocardial Ischemia / Q000097:blood / Q000188:drug therapy* / Q000503:physiopathology; D016896:Treatment Outcome; D014280:Triglycerides / Q000097:blood
D004042:Dietary Fats, Unsaturated; D005395:Fish Oils; D008074:Lipoproteins; D014280:Triglycerides; C089938:eiconol; D002784:Cholesterol
Primenenie éĭkonola u bolńykh ishemicheskoĭ bolezníu serdtsa.